What are the appropriate admitting orders for managing electrolyte imbalances and preventing progression to acute kidney injury?

Medical Management Admitting Orders for Electrolyte Imbalance Secondary to AKI

For patients admitted with electrolyte imbalances secondary to AKI, immediately discontinue all nephrotoxic medications, initiate isotonic crystalloid resuscitation (avoiding colloids), establish frequent monitoring protocols for serum creatinine and electrolytes, and prepare for renal replacement therapy if refractory hyperkalemia, volume overload, or intractable acidosis develops. 1, 2

Initial Assessment and Monitoring Orders

Immediate Laboratory Workup

• Serum creatinine, complete blood count, comprehensive metabolic panel including sodium, potassium, chloride, bicarbonate, calcium, magnesium, and phosphate 2
• Urinalysis with microscopy and fractional excretion of sodium (FENa) to classify AKI as prerenal, intrinsic, or postrenal 2
• Renal ultrasound to rule out obstruction, particularly critical in older male patients 2
• Repeat electrolyte panels every 6-12 hours during acute phase, as electrolyte shifts occur rapidly in AKI 3, 4

Hemodynamic Monitoring

• Strict intake and output monitoring with goal of euvolemia 4
• Daily weights 4
• Assessment of volume status through physical examination (jugular venous pressure, edema, orthostatic vital signs) 2

Fluid Management

Volume Resuscitation Strategy

• Use isotonic crystalloids (0.9% saline or Ringer's lactate) as first-line therapy for intravascular volume expansion 1
• Avoid colloids including albumin and hydroxyethyl starches, as the 6S Trial demonstrated increased mortality, need for renal replacement therapy, and bleeding with HES 130/0.42 compared to crystalloids in septic patients 1
• Avoid overzealous fluid resuscitation which can precipitate pulmonary edema without preventing AKI progression 1

Medication Management

Nephrotoxic Agent Review

• Immediately discontinue or hold all potentially nephrotoxic medications including NSAIDs, aminoglycosides, vancomycin, amphotericin B, and contrast agents 1, 2
• Review and adjust doses of renally-cleared medications to prevent accumulation and toxicity 1
• Do not withhold life-saving medications (including IV contrast) in life-threatening situations due to AKI concerns 1
• Exercise particular caution with diuretics combined with SGLT2 inhibitors or ACE inhibitors/ARBs, as these combinations increase AKI risk 5

Hemodynamic Medications

• Avoid or carefully titrate medications causing systemic hypotension or altered intraglomerular hemodynamics (afferent arteriole constrictors, efferent arteriole dilators) 1

Specific Electrolyte Management

Hyperkalemia

• Continuous cardiac monitoring for potassium >5.5 mEq/L 3
• Treatment algorithm based on severity and ECG changes:
  • Calcium gluconate 10% (10-20 mL IV) for cardiac membrane stabilization if ECG changes present 3
  • Insulin (10 units regular) with dextrose (25-50g) for intracellular potassium shift 3
  • Sodium bicarbonate if concurrent metabolic acidosis 3
  • Potassium-binding resins or patiromer for non-emergent cases 3
  • Prepare for urgent dialysis if refractory to medical management 2, 6

Hyponatremia

• Determine volume status first (hypovolemic, euvolemic, or hypervolemic) as this dictates treatment 3
• Correct slowly at rate of 6-8 mEq/L per 24 hours to avoid osmotic demyelination syndrome 3
• Monitor sodium every 2-4 hours during active correction 3
• Be aware that hyponatremia prevalence increases with diuretic use (particularly furosemide), occurring in 17.5% of patients on combined therapy 5

Hypocalcemia and Hypomagnesemia

• Correct magnesium deficiency before treating hypocalcemia, as hypomagnesemia impairs PTH secretion and calcium repletion 3
• Calcium supplementation guided by ionized calcium levels 3

Hypophosphatemia

• Monitor closely in patients receiving high-dose or prolonged CRRT, as this can paradoxically cause severe hypophosphatemia 7
• Phosphate repletion based on severity, with IV replacement for levels <1.0 mg/dL 3

Metabolic Acidosis

• Address underlying cause rather than empiric bicarbonate administration 6
• Consider bicarbonate therapy for pH <7.1-7.2 with hemodynamic instability 3

Indications for Renal Replacement Therapy

Prepare for urgent dialysis initiation when any of the following develop 2, 6:

• Refractory hyperkalemia unresponsive to medical management
• Volume overload with pulmonary edema refractory to diuretics
• Intractable metabolic acidosis
• Uremic complications: encephalopathy, pericarditis, or pleuritis
• Specific toxin removal (methanol, ethylene glycol, lithium)

CRRT Considerations

• CRRT preferred over intermittent hemodialysis in hemodynamically unstable patients for better hemodynamic stability and controlled electrolyte correction 8, 7
• Individualized dialysate and replacement fluid prescriptions can prevent paradoxical electrolyte disturbances (hypokalemia, hypophosphatemia) during therapy 7
• Close monitoring required as errors in CRRT fluid prescription can be rapidly fatal 8

Risk Stratification and Prevention

High-Risk Patient Identification

• Age ≥60 years (22-fold increased odds of multi-morbidity in SA-AKI) 9
• Chloride and albumin imbalances are significant risk factors for multi-morbidity 9
• Comorbidities: hypertension (52.4%), diabetes mellitus (46.5%) 9

Common Pitfalls to Avoid

• Do not use colloids for volume resuscitation despite theoretical advantages as plasma expanders 1
• Avoid combining furosemide with dapagliflozin, as this significantly increases AKI risk (p=0.006) 5
• Do not rapidly correct chronic hyponatremia, as this risks osmotic demyelination 3
• Ensure magnesium repletion before calcium to enable effective correction 3

Transition Planning

Post-AKI Management

• Coordinate care with nephrology and primary care for long-term follow-up 1
• Monitor for CKD progression, hypertension, proteinuria, and cardiovascular events at regular intervals 1
• Apply KDOQI CKD guidelines for ongoing management 1